AGP Picks
View all

Chemicals Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.

Press releases published on November 9, 2026

Solomon Global Offers Exclusive Signed Una and the Lion 2027 Gold Bullion Coins
Dresner Partners Advised Adoro Medical Spa on Its Sale to Well Labs+
2026 state mental health rankings released by Mental Health America
TalkingParents Launches Service Appreciation Discount for Military Members and First Responders
Popcorn Company Parodies Elizabeth Holmes' Iconic Photo in Viral X Ad, Helping Surpass $1 Million Fundraising Goal
Reach Security Recognized as a CRN® 2026 Stellar Startup
Baylor Genetics to Highlight the Clinical Value of Genomics in Pediatric Care at the 2026 National Society of Genetic Counselors Annual Meeting
Software Safety Institute Launches to Reduce Preventable Harm from Insecure Software
Redodo Announces Black Friday Sale with Up to 60% Off LiFePO4 Batteries
Make New Family Holiday Memories for Less at Jellystone Park Camp-Resorts
Freight Club Leadership Joins Freight Right to Build Out Direct-to-Consumer Ecommerce and Dropshipping for Large Goods
DesignTo Clothing Announces Small-Batch Custom Apparel Production Options for Startup Brands
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
National Advertising Division Found Unilever’s Dove Deep Moisture Body Wash Claims Supported
Kraig Labs Ships Spider Silk to Developers Across Global Industries
From Artemis to Supersonic Flight, the President Takes the Aerospace Agenda to the Space Coast
CloudTalk launches a new AI Sales Dialer for even more live conversations: Customers report going from 15 to 100+ calls per agent per day
Boehringer Ingelheim's survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase III SYNCHRONIZE-CVOT trial alongside significant cardiometabolic benefits
Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase 3 SYNCHRONIZE-CVOT trial with significant cardiometabolic benefits
FHLBank Atlanta Awards $50.4 Million to Advance Affordable Housing Across 50 Developments

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Chemicals Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.